SELLAS LIFE SCIENCES GROUP I (SLS) Stock Analyst Earnings Estimates
NASDAQ:SLS - Nasdaq - US81642T2096 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.9M | 7.6M 300.00% | 1M -86.84% | 13.13M -100.00% | 16.589M | 89.987M 442.45% | 160.29M 78.13% | 253.83M 58.36% | 407.78M 60.65% | 537.3M 31.76% | |||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -16.98M 1.34% | -19.59M -15.37% | -31.95M -63.09% | -29.545M -18.53% | -32.466M 14.27% | -36.047M -11.03% | -38.499M -6.80% | -6.02M 84.36% | 83.246M 1,482.80% | 156.59M 88.11% | 278.21M 77.67% | 380.23M 36.67% | |
| Operating Margin | -893.68% | -257.76% | -3,195.00% | -225.02% | N/A | N/A | -232.07% | -6.69% | 51.93% | 61.69% | 68.23% | 70.77% | |
| EPS YoY % growth | N/A 91.58% | -1.33 27.25% | -2.23 -67.67% | -1.10 39.01% | -0.54 60.17% | -0.48 12.31% | -0.49 -3.47% | -0.09 82.53% | 1.12 1,405.88% | 2.05 82.88% | 3.57 73.89% | 4.75 33.14% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 56.64% | -0.12 42.29% | -0.11 14.54% | -0.11 -11.10% | -0.11 -2.49% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.554M 7.62% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.10 69.70% | -0.13 | 0.03 | 23.84% |
| Q2 2024 Q2Q % growth | -0.13 58.06% | -0.17 | 0.04 | 21.99% |
| Q1 2024 Q2Q % growth | -0.21 55.32% | -0.16 | -0.05 | -29.95% |
| Q4 2023 Q2Q % growth | -0.25 41.86% | 0.00 | -0.25 | -8,900.90% |
| Q3 2023 Q2Q % growth | -0.33 2.94% | 0.03 | -0.36 | -1,189.11% |
| Q2 2023 Q2Q % growth | -0.31 24.39% | -0.36 | 0.05 | 13.54% |
| Q1 2023 Q2Q % growth | -0.47 55.24% | -0.29 | -0.18 | -59.55% |
| Q4 2022 Q2Q % growth | -0.43 -2.38% | -0.32 | -0.11 | -33.04% |
| Q3 2022 Q2Q % growth | -0.34 24.44% | -0.39 | 0.05 | 12.94% |
| Q2 2022 Q2Q % growth | -0.41 -36.67% | -0.35 | -0.06 | -15.98% |
| Q1 2022 Q2Q % growth | -1.05 -556.25% | -0.38 | -0.67 | -173.58% |
| Q4 2021 Q2Q % growth | -0.42 -50.00% | -0.41 | -0.01 | -1.42% |
| Q3 2021 Q2Q % growth | -0.45 15.09% | -0.38 | -0.07 | -18.29% |
| Q2 2021 Q2Q % growth | -0.30 54.55% | -0.39 | 0.09 | 23.84% |
| Q1 2021 Q2Q % growth | -0.16 78.59% | -0.27 | 0.11 | 41.33% |
| Q4 2020 Q2Q % growth | -0.28 81.82% | -0.28 | 0.00 | -0.81% |
| Q3 2020 Q2Q % growth | -0.53 80.22% | -0.31 | -0.22 | -72.05% |
| Q2 2020 Q2Q % growth | -0.66 89.85% | -0.65 | -0.01 | -2.10% |
| Q1 2020 Q2Q % growth | 93.21% | -0.75 | % | |
| Q4 2019 Q2Q % growth | -1.54 | -0.73 | -0.81 | -110.31% |
| Q3 2019 Q2Q % growth | -2.68 | -1.01 | -1.67 | -165.35% |
| Q2 2019 Q2Q % growth | -6.50 | -9.09 | 2.59 | 28.49% |
| Q1 2019 Q2Q % growth | -11.00 | -10.35 | -0.65 | -6.25% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 13.13M | -13.13M | -100.00% | |
| Q3 2023 Q2Q % growth | 8.753M | -8.753M | -100.00% | |
| Q2 2023 Q2Q % growth | 3.283M | -3.283M | -100.00% | |
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | 1M -82.46% | % | ||
| Q4 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -0.34% | 6.73% |
| Revenue | N/A | N/A | N/A | N/A |